Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ari Kane

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Neurosurgery Clinics of North America|December 1, 2009
Interferon-gamma in brain tumor immunotherapyAri Kane, Isaac Yang
Cureus|October 22, 2015
Meningiomas of the Anterior Clinoid Process: Is It Wise to Drill Out the Optic Canal?Michael Sughrue, Ari Kane, Martin J Rutkowski, et al.
The Journal of Clinical Endocrinology and Metabolism|October 16, 2019
Long-Term Outcomes of 125 Patients With Metastatic Pheochromocytoma or Paraganglioma Treated With 131-I MIBGMatthew P Thorpe, Ari Kane, Jason Zhu, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|May 20, 2018
Predictors of Survival in 211 Patients with Stage IV Pulmonary and Gastroenteropancreatic MIBG-Positive Neuroendocrine Tumors Treated with <sup>131</sup>I-MIBGAri Kane, Matthew P Thorpe, Michael A Morse, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Neurosurgery Clinics of North America|December 1, 2009
Interferon-gamma in brain tumor immunotherapyAri Kane, Isaac Yang
Cureus|October 22, 2015
Meningiomas of the Anterior Clinoid Process: Is It Wise to Drill Out the Optic Canal?Michael Sughrue, Ari Kane, Martin J Rutkowski, et al.
The Journal of Clinical Endocrinology and Metabolism|October 16, 2019
Long-Term Outcomes of 125 Patients With Metastatic Pheochromocytoma or Paraganglioma Treated With 131-I MIBGMatthew P Thorpe, Ari Kane, Jason Zhu, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|May 20, 2018
Predictors of Survival in 211 Patients with Stage IV Pulmonary and Gastroenteropancreatic MIBG-Positive Neuroendocrine Tumors Treated with <sup>131</sup>I-MIBGAri Kane, Matthew P Thorpe, Michael A Morse, et al.
Pageof 1